ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005

NCI Director Harold Varmus Plans New Center For Cancer Genomics To Lead The Cancer Genome Atlas Program.

September 10, 2010